Understand how to mechanical and biological forces influence metastasis.

Leverage genetic signatures obtained from single-cell sequencing to generate patient-specific information and offer personalised medicine.

Non-invasive, less expensive and more efficient alternative to clinical trials.

Applicable to various cancer types, including ovarian, gastric, prostate, pancreatic, and colorectal cancers.